Skip to Main Content

Advertisement intended for health care professionals

Close

ASH Clinical News
ASH News Daily
ASH-SAP
Blood Journals
Hematology
The Hematologist
International
ASH
- ASH Home
- Research
- Education
- Advocacy
- Meetings
- Publications
- ASH Store

header search

search input Search input auto suggest

filter your search

Search

Menu

Issues
- Current Issue
- All Issues
First edition
Abstracts
Collections
Author Center
About

Skip Nav Destination

Issue Archive

Select Decade

Select Year

Issue

Volume 126, Issue 20

November 12 2015

In this Issue

INSIDE BLOOD COMMENTARIES
REVIEW ARTICLE
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
LYMPHOID NEOPLASIA
MYELOID NEOPLASIA
PLATELETS AND THROMBOPOIESIS
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
BLOOD WORK
CORRESPONDENCE

Table of Contents

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY

Osteoclast activation and sickle bone disease

Victor R. Gordeuk

View Articletitled, Osteoclast activation and sickle bone disease

INSIDE BLOOD COMMENTARY

Lucky 13

David H. Farrell

View Articletitled, Lucky 13

INSIDE BLOOD COMMENTARY

Free hemoglobin: a boost to platelet thrombi

Marc Jacquemin,Kathelijne Peerlinck

View Articletitled, Free hemoglobin: a boost to platelet thrombi

REVIEW ARTICLE

Familial predisposition and genetic risk factors for lymphoma

James R. Cerhan,Susan L. Slager

View Articletitled, Familial predisposition and genetic risk factors for lymphoma

HOW I TREAT

How I treat posttransplant lymphoproliferative disorders

Daan Dierickx,Thomas Tousseyn,Olivier Gheysens

View Articletitled, How I treat posttransplant lymphoproliferative disorders

CLINICAL TRIALS AND OBSERVATIONS

Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma
Clinical Trials & Observations

Jatin J. Shah,Edward A. Stadtmauer,Rafat Abonour,Adam D. Cohen,William I. Bensinger,Cristina Gasparetto,Jonathan L. Kaufman,Suzanne Lentzsch,Dan T. Vogl,Christina L. Gomes,Natalia Pascucci,David D. Smith,Robert Z. Orlowski,Brian G. M. Durie

View Articletitled, Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma

LYMPHOID NEOPLASIA

ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humans

Karen S. Hathcock,Hesed M. Padilla-Nash,Jordi Camps,Dong-Mi Shin,Daniel Triner,Arthur L. Shaffer, III,Robert W. Maul,Seth M. Steinberg,Patricia J. Gearhart,Louis M. Staudt,Herbert C. Morse, III,Thomas Ried,Richard J. Hodes

View Articletitled, ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humans

Supplemental data

MYELOID NEOPLASIA

High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia
Clinical Trials & Observations Brief Report

Antonio R. Lucena-Araujo,Haesook T. Kim,Carolina Thomé,Rafael H. Jacomo,Raul A. Melo,Rosane Bittencourt,Ricardo Pasquini,Katia Pagnano,Ana Beatriz F. Glória,Maria de Lourdes Chauffaille,Melina Athayde,Carlos S. Chiattone,Ingrid Mito,Rodrigo Bendlin,Carmino Souza,Cristina Bortolheiro,Juan L. Coelho-Silva,Stanley L. Schrier,Martin S. Tallman,David Grimwade,Arnold Ganser,Nancy Berliner,Raul C. Ribeiro,Francesco Lo-Coco,Bob Löwenberg,Miguel A. Sanz,Eduardo M. Rego

View Articletitled, High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia

Supplemental data

PLATELETS AND THROMBOPOIESIS

The ABCC4 membrane transporter modulates platelet aggregation

Satish B. Cheepala,Aaron Pitre,Yu Fukuda,Kazumasa Takenaka,Yuanyuan Zhang,Yao Wang,Sharon Frase,Tamara Pestina,T. Kent Gartner,Carl Jackson,John D. Schuetz

View Articletitled, The ABCC4 membrane transporter modulates platelet aggregation

Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease

Luca Dalle Carbonare,Alessandro Matte’,Maria Teresa Valenti,Angela Siciliano,Antonio Mori,Vittorio Schweiger,Gino Zampieri,Luigi Perbellini,Lucia De Franceschi

View Articletitled, Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease

Supplemental data

THROMBOSIS AND HEMOSTASIS

Coagulation factor XIIIa is inactivated by plasmin

Woosuk S. Hur,Nima Mazinani,X. J. David Lu,Heidi M. Britton,James R. Byrnes,Alisa S. Wolberg,Christian J. Kastrup

View Articletitled, Coagulation factor XIIIa is inactivated by plasmin

Supplemental data

Free hemoglobin increases von Willebrand factor–mediated platelet adhesion in vitro: implications for circulatory devices
Brief Report

Qi Da,Miho Teruya,Prasenjit Guchhait,Jun Teruya,John S. Olson,Miguel A. Cruz

View Articletitled, Free hemoglobin increases von Willebrand factor–mediated platelet adhesion in vitro: implications for circulatory devices

Supplemental data

BLOOD WORK

Lymphoplasmacytic lymphoma with prominent mast cell infiltrates

Mark Benedict,S. David Hudnall

View Articletitled, Lymphoplasmacytic lymphoma with prominent mast cell infiltrates

Adult T-cell leukemia/lymphoma

Marcos Arango,Carolina Echeverri

View Articletitled, Adult T-cell leukemia/lymphoma

CORRESPONDENCE

ETV3-NCOA2 in indeterminate cell histiocytosis: clonal translocation supports sui generis

Ryanne A. Brown,Bernice Y. Kwong,Timothy H. McCalmont,Bruce Ragsdale,Lisa Ma,Christine Cheung,Kerri E. Rieger,Daniel A. Arber,Jinah Kim

View Articletitled, <em>ETV3-NCOA2</em> in indeterminate cell histiocytosis: clonal translocation supports sui generis

Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience
Clinical Trials & Observations

Vaishali Sanchorawala,Fangui Sun,Karen Quillen,J. Mark Sloan,John L. Berk,David C. Seldin

View Articletitled, Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience

Cover Image

Cover Image

Representative image of calcein-labeled bone surface evaluating dynamic bone turnover in humanized sickle cell mice exposed to recurrent acute vaso-occlusive crisis treated with zoledronic acid to suppress osteoclastogenesis and modulate osteoblastogenesis. See the article by Dalle Carbonare et al on page 2320.
Front Matter
Table of Contents
Back Matter
Advertising
Editorial Board

Advertisement intended for health care professionals

Email alerts

First Edition Alert

Latest Issue Alert

Latest
Most Read
Most Cited

Licking the wound with procoagulant vesicles

Approaching Hypercalcemia in Monoclonal Gammopathy of Undetermined Significance: Insights from the iStopMM study

CAR T-cells in autoimmunity: game changer or stepping stone?

Long-Term Efficacy and Safety of Danicopan as Add-On Therapy to Ravulizumab or Eculizumab in PNH With Significant EVH

How I treat quantitative fibrinogen disorders

Advertisement intended for health care professionals

Advertisement intended for health care professionals

Current Issue
First edition
All Issues

Collections
Abstracts
Authors

Submit to Blood
About Blood
Subscriptions

Public Access
Permissions
Alerts

Contact Us
Newsroom
Blood Classifieds

Advertising in Blood
Terms and Conditions
Twitter

American Society of Hematology
2021 L Street NW, Suite 900
Washington, DC 20036
TEL +1 202-776-0544
FAX +1 202-776-0545

ASH Publications

Blood
Blood Advances
Blood Global Hematology
Blood Neoplasia
Blood Vessels, Thrombosis & Hemostasis
Hematology, ASH Education Program
ASH Clinical News
ASH-SAP
The Hematologist

American Society of Hematology

ASH Home
Research
Education
Advocacy
Meetings
Publications
ASH Store

Copyright 2024 by American Society of Hematology

Cookie Settings
Privacy Policy
Cookie Policy
Terms of Use
Contact Us

This Feature Is Available To Subscribers Only

Sign In or Create an Account

Advertisement intended for health care professionals